Replies to post #68771 on Innovation Pharmaceuticals Inc (IPIX)

[Whoops]

I am liking the theory that K is not expected to DLT at 350 since this is well beyond estimated therapeutic range they are just looking at declaring a high safe dose and move on. But, would this last cohort then be a expanded cohort even without the DLT?